Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trialXiaotian Zhang, Jiafu Ji, Xiangji Ying et al.|The Lancet Oncology|2021Cited by 436
A Comparison of Whole-Genome Shotgun-Derived Mouse Chromosome 16 and the Human GenomeRichard Mural, Deborah Nusskern, Mark D. Adams et al.|Science|2002Cited by 370
The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencingWenli Zhou, Yunsheng Yang, De Zhang et al.|Journal of Translational Medicine|2021Cited by 91
miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44Lina Sun, Xin Wang|Theranostics|2019Cited by 86
LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradationLina Zhu, Xin Wang|Nature Communications|2023Cited by 67